Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

This study has been terminated.
(investigation of adverse events in a related clinical study)
Sponsor:
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00869856
First received: March 25, 2009
Last updated: August 20, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)